Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors
Clinical trial NCT05800964 · COMPLETED
Trial details
- NCT number
- NCT05800964
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-13
- Primary completion
- 2026-01-22
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.